发明名称 |
Use of an anti-Ang2 antibody |
摘要 |
A method of preventing or treating cancer using an anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes to a Tie2 receptor while bound with Ang2. |
申请公布号 |
US9505841(B2) |
申请公布日期 |
2016.11.29 |
申请号 |
US201414446199 |
申请日期 |
2014.07.29 |
申请人 |
SAMSUNG ELECTRONICS CO., LTD.;KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
发明人 |
Kim Kyung Eun;Han Sang Yeul;Koh Gou Young;Lee Hyo Seon;Kim Chan |
分类号 |
A61K39/395;C07K16/28;C07K16/22;A61K38/17;A61K45/06;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Leydig, Voit & Mayer, Ltd. |
代理人 |
Leydig, Voit & Mayer, Ltd. |
主权项 |
1. A method of enhancing the efficacy of an anticancer agent, comprising administering an anti-cancer agent and an anti-Ang2 antibody or an antigen-binding fragment thereof to a subject in need thereof, wherein the anti-Ang2 antibody or the antigen-binding fragment thereof specifically binds to Ang2 and forms a complex with a Tie2 receptor via Ang2; and the anti-Ang2 antibody or an antigen-binding fragment thereof binds to Q418, P419 or a combination of Q418 and P419 in human Ang2 of SEQ ID NO: 11; or binds to 2 to 20 contiguous amino acid residues of SEQ ID NO: 11 including Q418, P419 or a combination of Q418 and P419,
wherein the anti-Ang2 antibody or an antigen-binding fragment thereof comprises: a first heavy chain complementarity determining region (CDR-H1) comprising the amino acid sequence of SEQ ID NO: 1, a second heavy chain complementarity determining region (CDR-H2) comprising the amino acid sequence of SEQ ID NO: 2, a third heavy chain complementarity determining region (CDR-H3) comprising the amino acid sequence of SEQ ID NO: 3, a first light chain complementarity determining region (CDR-L1) comprising the amino acid sequence of SEQ ID NO: 4, a second light chain complementarity determining region (CDR-L2) comprising the amino acid sequence of SEQ ID NO: 5, and a third light chain complementarity determining region (CDR-L3) comprising the amino acid sequence of SEQ ID NO: 6. |
地址 |
Suwon-Si KR |